However, when comparing gene-edited HD TCR − CAR T cells with lymphoma CAR T cells, this difference did not reach statistical significance.
← all excerpts
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.
1
—
—